SCM

Suvretta Capital Management Portfolio holdings

AUM $2.65B
1-Year Return 18.59%
This Quarter Return
+16.38%
1 Year Return
+18.59%
3 Year Return
+180.23%
5 Year Return
+278.12%
10 Year Return
+1,101.07%
AUM
$5.54B
AUM Growth
+$889M
Cap. Flow
+$358M
Cap. Flow %
6.47%
Top 10 Hldgs %
41.34%
Holding
123
New
42
Increased
33
Reduced
14
Closed
29

Sector Composition

1 Technology 23.25%
2 Consumer Discretionary 19.88%
3 Healthcare 17.75%
4 Industrials 15.34%
5 Communication Services 10.82%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
AUPH icon
51
Aurinia Pharmaceuticals
AUPH
$1.65B
$10.8M 0.2%
735,500
+579,800
+372% +$8.54M
TWND.U
52
DELISTED
Tailwind Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one warrant
TWND.U
$10.1M 0.18%
+1,000,000
New +$10.1M
MRNS
53
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$10M 0.18%
779,725
+279,725
+56% +$3.59M
ASTR
54
DELISTED
Astra Space, Inc. Class A Common Stock
ASTR
$10M 0.18%
+100,000
New +$10M
NVAX icon
55
Novavax
NVAX
$1.27B
$8.77M 0.16%
+80,914
New +$8.77M
SLNO icon
56
Soleno Therapeutics
SLNO
$3.7B
$8.1M 0.15%
215,117
+46,625
+28% +$1.76M
CLOVW
57
DELISTED
Clover Health Investments, Corp. Warrants
CLOVW
$7.88M 0.14%
2,042,469
+1,198,273
+142% +$4.63M
LGND icon
58
Ligand Pharmaceuticals
LGND
$3.27B
$7.36M 0.13%
+123,774
New +$7.36M
SNPR.U
59
DELISTED
Tortoise Acquisition Corp. II Units, each consisting of one Class A ordinary share and one-fourth of
SNPR.U
$7.07M 0.13%
+650,000
New +$7.07M
TPTX
60
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
$6.93M 0.12%
79,331
+54,100
+214% +$4.73M
PRLD icon
61
Prelude Therapeutics
PRLD
$64.5M
$6.78M 0.12%
+225,000
New +$6.78M
CANO
62
DELISTED
Cano Health, Inc.
CANO
$5.46M 0.1%
+5,246
New +$5.46M
ASTRW
63
DELISTED
Astra Space, Inc. Warrant
ASTRW
$5M 0.09%
+499,999
New +$5M
CHMA
64
DELISTED
Chiasma, Inc. Common Stock
CHMA
$4.48M 0.08%
1,041,556
+847,751
+437% +$3.65M
CHRS icon
65
Coherus Oncology, Inc. Common Stock
CHRS
$152M
$4.37M 0.08%
238,100
+56,800
+31% +$1.04M
FSDC
66
DELISTED
FS Development Corp. Class A Common Stock
FSDC
$3.92M 0.07%
+350,000
New +$3.92M
KALV icon
67
KalVista Pharmaceuticals
KALV
$765M
$3.89M 0.07%
308,900
+61,900
+25% +$779K
SYRE icon
68
Spyre Therapeutics
SYRE
$1.03B
$3.75M 0.07%
21,164
+16,447
+349% +$2.91M
OPENW
69
DELISTED
Opendoor Technologies Inc Warrants expiring 12/18/2025
OPENW
$3.74M 0.07%
673,677
+269,011
+66% +$1.49M
KURA icon
70
Kura Oncology
KURA
$706M
$3.65M 0.07%
+119,000
New +$3.65M
KYMR icon
71
Kymera Therapeutics
KYMR
$3.02B
$3.56M 0.06%
+110,230
New +$3.56M
NAUT icon
72
Nautilus Biotechnolgy
NAUT
$82.3M
$3.25M 0.06%
+300,000
New +$3.25M
BMY.RT
73
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
$2.93M 0.05%
1,300,968
-3,460,151
-73% -$7.78M
KDNY
74
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$2.77M 0.05%
228,256
+67,676
+42% +$822K
KZR icon
75
Kezar Life Sciences
KZR
$28M
$2.69M 0.05%
55,590